Home › Steatotische leveraandoening › Florida › Ocala
Steatotische leveraandoening klinische studies in Ocala, FL
8 studies voor Steatotische leveraandoening zoeken deelnemers op locaties in en rond Ocala (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RekruterenFase 3
- 89bio Clinical Study Site, Ocala
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RekruterenFase 3
- 89bio Clinical Study Site, Ocala
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekruterenFase 3
- GSK Investigational Site, Ocala
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekruterenFase 3
- GSK Investigational Site, Ocala
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RekruterenFase 3
- Akero Clinical Study Site, Ocala
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RekruterenFase 3
- GSK Investigational Site, Ocala
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekruterenFase 2
- Ocala GI Research, Ocala
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RekruterenFase 3
- GSK Investigational Site, Ocala
Steatotische leveraandoening studies in andere steden
- San Antonio, TX17 studies
- New York City, NY16 studies
- Miami, FL16 studies
- San Diego, CA14 studies
- Austin, TX13 studies
- Houston, TX13 studies
- Richmond, VA12 studies
- Tucson, AZ10 studies
- Chandler, AZ10 studies
- Hialeah, FL9 studies
- Dallas, TX9 studies
- Orlando, FL9 studies
Andere studies in Ocala
- Niet-kleincellige longkanker10 studies
- Obesitas7 studies
- Overgewicht6 studies
- Ziekte van Alzheimer6 studies
- Hartfalen5 studies
- COPD5 studies
- Leveraandoeningen3 studies
- Chronische pijn3 studies
- Lichte cognitieve beperking3 studies
- Metastatische kanker3 studies
- Cardiovasculaire ziekte3 studies
- Atherosclerose3 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.